000 | 01788 a2200505 4500 | ||
---|---|---|---|
005 | 20250516012459.0 | ||
264 | 0 | _c20110504 | |
008 | 201105s 0 0 eng d | ||
022 | _a1479-6821 | ||
024 | 7 |
_a10.1677/ERC-10-0234 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLibertini, Silvana | |
245 | 0 | 0 |
_aAZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947. _h[electronic resource] |
260 |
_bEndocrine-related cancer _cFeb 2011 |
||
300 |
_a129-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 | _aOncolytic Virotherapy |
650 | 0 | 4 |
_aOncolytic Viruses _xphysiology |
650 | 0 | 4 |
_aOrganophosphates _xpharmacology |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aQuinazolines _xpharmacology |
650 | 0 | 4 | _aThyroid Carcinoma, Anaplastic |
650 | 0 | 4 |
_aThyroid Neoplasms _xpathology |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aAbagnale, Antonella | |
700 | 1 | _aPassaro, Carmela | |
700 | 1 | _aBotta, Ginevra | |
700 | 1 | _aBarbato, Sara | |
700 | 1 | _aChieffi, Paolo | |
700 | 1 | _aPortella, Giuseppe | |
773 | 0 |
_tEndocrine-related cancer _gvol. 18 _gno. 1 _gp. 129-41 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1677/ERC-10-0234 _zAvailable from publisher's website |
999 |
_c20369240 _d20369240 |